the same set of articles-those chosen to give the psychosocial perspective its best shot-and many of these studies were observational designs representing the core of social epidemiology. The 'negative' speakers commenting on the evidence were the current and the former editors of the New England Journal of Medicine. Their criticisms, interestingly enough, were not unique to the domain of social epidemiology studies, but were part of the traditional list of methodological weaknesses, such as: (1) data dredging; (2) failure to account for confounders; and (3) abandoning the 'intent-to-treat' data analysis guidelines for randomized clinical trials. Thus it remains unclear if research in social epidemiology has some unique challenges, or if it simply has more ample weaknesses of the traditional kind. Interestingly, Drs Rellman and Angell did some ideological boundary-setting of their own: for example, they refused to be interested in psychosocial effects on physical health which were mediated by lifestyle habits or adherence.
This issue of the International Journal of Epidemiology contains a number of articles that fall within the domain of social epidemiology. Presumably, they represent submitted (not solicited) papers that were accepted and are assembled together in one issue, but are not meant to define the field in any way. They represent a nice range of illustrative studies, but they do not constitute a comprehensive picture of the field. The boundaries of social epidemiology-the study of social and psychological determinants of health-are neither sharp nor unchanging. Perhaps the recent volume, Social Epidemiology, edited by Berkman and Kawachi, 8 can be used to illustrate some of the important research themes. Among others, it contains chapters on: (1) socioeconomic position, income inequality, and discrimination; (2) working conditions and job loss; (3) social integration and social cohesion; (4) depression and other affective states; (5) social context of health behaviours and psychosocial interventions; and (6) ecological and multilevel approaches to social determinants.
In the commentary that follows, we seek to achieve a better understanding of the methodological and conceptual issues (difficulties) that arise when one is examining psychosocial influences on health within the context of a biomedical aetiology of disease. In other words, we believe that there are different or new challenges in social epidemiological research that go beyond those encountered in classical (biomedical) epidemiological approaches. First, we will identify and briefly describe some of these challenges. Then we will make specific comments on some of the articles with a view toward providing concrete illustrations of these points. We realize, of course, that our views may be somewhat idiosyncratic and that other investigators and scholars in this field would express these issues differently. Above all, we believe that social epidemiology is a true integration of the biomedical and the social/ behavioural disciplines, rather than a purely social/behavioural approach to the study of health issues on a population level. Given that, the primary concern is to account for the role (mechanisms) of psychosocial risk factors in biomedical aetiology of disease. Often, this involves keeping track of four inter-related issues: (1) study design; (2) measurement of exposure/risk factors; (3) data analysis strategies (in the service of clarifying aetiological pathways); and (4) aetiological theory about how exposure affects outcomes.
In classical epidemiology, our risk factors often come with their own biological plausibility, i.e. mechanisms of disease causation. For example, the way hyperuricaemia leads to gout is reasonably straightforward. On the other hand, the effect of social isolation on mortality is very unclear with respect to mechanisms involved. This ambiguity puts greater demands on our designs. Elsewhere, 9 we have discussed this in terms of the need to utilize a disease development paradigm: we need designs that will allow us to locate the influence of the social risk factor at a specific point in disease development. For coronary heart disease (CHD), the stages include: (1) asymptomatic status, risk factor(s) absent; (2) asymptomatic status, risk factor(s) present; (3) subclinical disease susceptible to detection; (4) initial symptom experience; (5) initial disease event (diagnostic criteria met); (6) course of disease; and (7) mortality (case fatality). Ideally, the design will allow us to determine which transition point(s) is (are) affected by the social variable.
In prospective designs in classical epidemiology, the biological risk factors at baseline are entered into multivariate models predicting outcomes obtained during follow-up. We seldom agonize about the aetiological process prior to baseline that might have produced the particular pattern of associations among the predictors. On the other hand, with a mix of psychosocial and biological predictors at baseline, disentangling causal priorities among them is often important to guide the analysis. But since the baseline data are cross-sectional, we are often unable to do so. Thus, if unemployment status is the baseline exposure in a mortality study, an association of unemployment with poor health status at baseline is ambiguous: poor health is a confounder if it led to the exposure but a mediator if it is already a consequence of the exposure. This again puts greater demands on our research designs and leads to the recommendation 9 that we should utilize the natural experiment paradigm whenever possible: this is a doubly prospective design (before disease and before exposure) which allows us to study the causal priorities among the variables which lead up to the exposure.
Biomedical risk factors are often 'silent' variables: people are unaware of them (e.g. low high density lipoprotein levels) or their impact is reasonably narrow (e.g. taking medication for high blood pressure). In contrast, psychosocial exposures can often be very 'reactive,' such as being in a demanding job or becoming unemployed: people respond and cope and adapt. This means that early on the exposure may have a different meaning than later on. This leads to complications such as: (1) length of exposure may lose meaning; (2) cohort follow-up may need to start at the beginning of exposure to detect effects; (3) the cohort may need to be monitored post-baseline for exposure-linked changes in behaviours, attitudes, perceptions, and so on.
It should be nearly self-evident that measurement of exposures in psychosocial epidemiology represents special challenges. For example, the distinction between 'objective' and 'subjective' measures would almost never come up in classical epidemiology but it is a major issue for certain research themes, such as the health effects of psychosocial work exposures. 10 
A persistent problem of measuring psychosocial exposures is that constructs, such as Type A behaviour, have been operationalized in different ways and do not show the same relationships to health outcomes. Often, we do not understand why; if we did, we might then argue that failure to replicate results really illustrates a high specificity of findings, but in most instances that would be an excessively optimistic interpretation. This (undesirably) high sensitivity of psychosocial measures to minor variations in operationalization (as well as to study designs, settings, type of respondents, and so on) remains a major obstacle to being able to argue that there is a convergence of findings.
At this point we wish to illustrate some of the points raised above by a selective commentary on a few of the articles published in this issue.
The job loss study from New Zealand 11 is a fine illustration of the strategy of looking for natural experiments that can provide us with an unbiased exposure (unlikely self-selection) and preexposure data. This becomes a strong, convincing design. Unfortunately, the data collection was minimal, based primarily on available records. Most sorely missed are any data on the reemployment experience of the cohort that was made redundant, and, to a lesser extent, the later job losses among those who initially continued working. Thus it becomes impossible to interpret the results, which suggest very weak effects, in comparison to the broad set of unemployment studies. 12 In addition, no information is given on the economic impact of the unemployment experience; in general, financial compensation tends to attenuate the impact of job loss, especially among lower skill blue collar workers. 12 It might also be noted that the one significant finding, the apparent high rate of self-harm (hospitalization or death) among those losing a job, is not as much a function of an increase from baseline, but a (puzzling) decrease among those who continued working in a presumably more insecure economy. This is somewhat reminiscent of results from a panel study of alcohol abuse and unemployment: 13 the big effect was the reduced risk for alcohol abuse among those who were employed, but the community rate of unemployment was going up. In psychosocial epidemiology, sometimes it takes us a while to understand our exposure variables! The study of job strain and CHD in the Nurses' Health Study 14 contributes negative results to a rather smallish set of studies that are not in agreement on the role of job strain among women as a CHD risk factor. The authors point out that since this was a study of a single occupation (thus making the title somewhat misleading with its reference to US women), there could have been an insufficient variability in the measures of the predictors. While this should have been easy to check, in our opinion this is not the important issue. Since the psychological demands and job control measure are a mix of descriptions of the work environment which may be shared by other workers (quasi-objective) and of idiosyncratic perceptions and reactions (subjective), then using the measures in a single occupation means that the quasi-objective component is reduced to near zero and the idiosyncratic component takes over almost completely. A related point is that the Karasek measures were developed for use across many occupations, but in a study of a single occupation, probably more targeted and precise measures of these concepts could be developed. It is possible that in the health professions (especially MD's) the great amount of job control and discretion becomes a source of psychological demands; thus in certain specific occupations, more precise measurement may be necessary. So while blood pressure remains blood pressure in classical epidemiology, sometimes our measures of psychosocial exposures change in meaning depending on contextual issues.
The Rosvall et al. study 15 also deals with job strain but the design is cross-sectional and the outcome is preclinical atherosclerosis. The results they obtained are rather puzzling: they do not fit the predictions from the job strain model and whether they reflect 'a more complex pattern of interaction' (abstract) which will stand up to replication is difficult to predict. The authors quote an earlier paper 16 in which one of us was making the recommendation regarding the perspective of the disease development schema, i.e. the study of psychosocial influences at different stages of the disease process. It is nice to be quoted, but the issue here is whether the recommendation must be implemented in longitudinal designs to get its full benefit. In a cross-sectional design in which cases with history of clinical disease have been removed, an association between a psychosocial variable and high plaque prevalence may be difficult to interpret: (1) it may mean that the variable increases the risk of progression from mere presence of risk factors to development of subclinical disease; or (2) it may mean that the variable is protective of the progression from subclinical disease to clinical events, thus leading to a greater accumulation of those with plaques. So while subclinical disease is a valuable outcome in psychosocial studies because it is a relatively 'silent' risk factor, thus avoiding the problem of reverse causation (disease influencing the risk factor), the full benefits of the strategy come in longitudinal designs, such as the study of hostility and subclinical progression. 17 The Sykes et al. study 18 poses the question of whether psychosocial variables could help explain the 'French paradox,' the combination of a diet high in saturated fats and lower CHD mortality. Since neither dietary data nor alcohol consumption is included in analysis, this makes it a very truncated look at the French paradox. Furthermore, no attempt is made to spell out the paradox in psychosocial terms so that a relevant set of variables would be used. Instead, the included variables are the traditional psychosocial risk factors from general cardiovascular epidemiology. The fact that none of them predicts hard outcomes is difficult to understand but relates to the common dilemma that minor variations in measurement may lead to rather different results. In any case, the observed negative profile of the risk factors for the French subjects becomes somewhat irrelevant to the study question posed, given the variables did not relate to CHD.
The study of self-assessed health (SAH) and mortality 19 represents an interesting paradox in psychosocial epidemiology: the basic finding of the association with mortality (after controlling for numerous variables, above all other indicators of health status) is an uncommonly robust one, yet we still cannot determine of this is an interesting finding or not. The danger that an unmeasured health status confounder will render this finding trivial leads to the open-ended goal of controlling for 'enough' potential confounders. What would confirm it as an interesting finding would be our ability to 'explain' (at least statistically) the association of SAH with mortality by another psychosocial construct. The present study attempts to do that but with no theoretical justification for the particular choice of the psychosocial variables. It is likely that the relevant construct, if there is one, is some specific optimism/pessimism about health; stressors or neuroticism or social support are only remotely promising and some have been tried before. The one large gap in our knowledge is that we do not know much about the behavioural and psychological consequences of positive and negative SAH. That is, nearly all studies control only for baseline covariates and we need follow-up monitoring of the cohort to see if there are intermediate consequences that are the mediators of the link to mortality. In addition, we need to pay closer attention to age as a moderator, since the meaning of SAH is likely to be different among young healthy people and older people with chronic conditions and disability. Parenthetically, we might also note that this robust evidence about SAH and mortality is difficult to translate into intervention strategies.
In this commentary we have tried to identify a number of conceptual and methodological challenges that we feel are common in studies in psychosocial epidemiology. Then we used some of the articles assembled in this issue to illustrate these challenges. Ultimately, we hope this will lead to a better understanding of psychosocial epidemiology by those who are not active participants in this research domain.
